Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.

21 total trials for this combination

Showing top 10 of 21 trials

Trials

NCT ID	Title	Status	Phase
NCT05123482	A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies	RECRUITING	PHASE1/PHASE2
NCT07214779	Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression	RECRUITING	—
NCT05116189	Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).	ACTIVE_NOT_RECRUITING	PHASE3
NCT00849667	Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse	TERMINATED	PHASE3
NCT00436774	Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01	UNKNOWN	—
NCT01379989	INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer	COMPLETED	PHASE3
NCT03170960	Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors	ACTIVE_NOT_RECRUITING	PHASE1
NCT03000192	HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life	UNKNOWN	—
NCT00263822	Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer	COMPLETED	PHASE3
NCT02855944	ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients	COMPLETED	PHASE3

Related Pages

All Ovarian cancer trials All trials in Cardiff, United Kingdom